drugset
Drugs / ApB DC vaccine
last change Sep 2012 re-read 3 minutes ago

ApB DC vaccine

Vaccine

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Sharon Riddler

Trials 1

today NCT00510497 · Ph 1/2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00510497 Jul 2007 → Sep 2012 HIV infectious disease Sharon Riddler Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ApB DC vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00510497 ↗
Modality Vaccine “a therapeutic vaccine” NCT00510497 ↗
Route Subcutaneous “Three vaccine doses will be administered subcutaneously every other week.” NCT00510497 ↗